Johnson & Johnson MedTech has announced the U.S. launch of the VIRTUGUIDE™ System, following the 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Pre-operative Planning Software. This AI-powered, patient-matched solution is designed to simplify the Lapidus procedure, a type of bunion surgery. Early reports indicate that the system can reduce surgical time by 30 minutes compared to traditional methods. The VIRTUGUIDE™ System, developed in collaboration with PeekMed®, is now available in the U.S., marking a significant advancement in surgical precision for bunion deformities.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。